Medtronic ‘Plays Offense’ Despite Pandemic Challenges, Q1 Results Provide Optimism
Medtronic’s revenue of $6.5bn in the first quarter of fiscal 2021 represents a 17% fall year-over-year, but it still beat analysts’ projections.
You may also be interested in...
NASS 2020: Medtronic Announces First Patient Implant With InterStim Micro, Adaptix Interbody System Launch
Medtronic’s next-generation InterStim Micro system for overactive bladder is more competitive with Axionics’ r-SNM system, according to an analyst. Medtronic continues to innovate as its former CEO announces retirement.
A new analysis of the WRAP IT study shows the Tyrx absorbable antibacterial envelope is a cost-effective tool for preventing infections around cardiac implantable electronic devices.
The medtech giant will simplify its organizational structure, consolidate operations and give more autonomy to its individual operating units.